How the pandemic transformed primary care for seniors

How the pandemic transformed primary care for seniors

During the Covid-19 pandemic, companies focused on primary care for seniors have been faced with the Herculean task of caring for an extremely vulnerable population. Not only did the deadly virus more acutely affect seniors, but also routine care for

Read More How the pandemic transformed primary care for seniors

FDA authorizes third Covid-19 vaccine, J&J pledges 20M shots by month’s end

FDA authorizes third Covid-19 vaccine, J&J pledges 20M shots by month’s end

The FDA has authorized Johnson & Johnson’s Covid-19 vaccine for emergency use, adding a third vaccination option—one that comes with storage and distribution advantages. The regulatory decision followed the review of an FDA advisory panel, which voted unanimously on Friday

Read More FDA authorizes third Covid-19 vaccine, J&J pledges 20M shots by month’s end

Otsuka launches pivotal trial of digital therapeutics for depression

Otsuka launches pivotal trial of digital therapeutics for depression

Otsuka Pharmaceutical is launching a virtual study to see if digital therapeutics can reduce depression symptoms. It’s the next step in a partnership between the Tokyo-based drugmaker and Click Therapeutics, a digital health startup that is developing programs for smoking

Read More Otsuka launches pivotal trial of digital therapeutics for depression

Metabolism myths: 7 things we get wrong about diet and exercise

New Scientist Default Image

Despite what you might have heard, your body is not a simple calorie-burning engine you can tweak at will to keep trim and stay healthy. Here are seven metabolic misconceptions you need to know Health 24 February 2021 By Herman

Read More Metabolism myths: 7 things we get wrong about diet and exercise

Merck commits $1.85B to Pandion in bid to boost immunology pipeline

ulcerative colitis

  Pandion Therapeutics is still in the earliest stage of testing its lead drug candidate in humans, but Merck sees enough potential for the biotech’s approach to autoimmune disease to plunk down $1.85 billion to buy the company outright. The

Read More Merck commits $1.85B to Pandion in bid to boost immunology pipeline

HHS Prep Act amendment could fail the nurses it aims to support

Translational medicine: A fresh take on how clinicians can battle burnout

For the last 12 months, our nation’s frontline healthcare workers have risked their own health and wellbeing to care for others. A recent report from the Joint Commission showed that fear of getting sick and bringing the novel coronavirus home

Read More HHS Prep Act amendment could fail the nurses it aims to support

GSK antibody falls short in hospitalized Covid-19 patients, but may help elderly

GSK commits $345M to Vir as alliance expands to flu, other respiratory viruses

  An experimental GlaxoSmithKline drug in testing for hospitalized Covid-19 patients failed to distance itself from standard treatment in a mid-stage clinical trial, but the pharmaceutical giant plans to continue testing the drug based on data suggesting the elderly might

Read More GSK antibody falls short in hospitalized Covid-19 patients, but may help elderly

FDA approves Sarepta drug for muscular dystrophy with rare genetic mutation

Text FDA Approved appearing behind ripped brown paper.

  The FDA has approved a Sarepta Therapeutics drug for Duchenne muscular dystrophy, clearing the way for the company to commercialize its third therapy for the rare, muscle-wasting disease. Thursday’s decision covers patients with a particular genetic mutation that affects

Read More FDA approves Sarepta drug for muscular dystrophy with rare genetic mutation

Cigna to purchase long-standing partner MDLive 

Cigna to purchase long-standing partner MDLive 

                  Only two months into 2021 and the health insurance arena is buzzing with activity. The latest in a string of big moves is Cigna’s plans to purchase telehealth company Miramar, Florida-based

Read More Cigna to purchase long-standing partner MDLive 

Does digital mental health need to rethink user engagement?

Highmark expands access to device that helps manage panic, PTSD symptoms

The Covid-19 pandemic has accelerated the conversation surrounding the potential for digital mental health applications to solve gaps in mental health care access—a welcome conversation given the enormous unmet need. But there is still little consensus among industry stakeholders around

Read More Does digital mental health need to rethink user engagement?